Development of an Anti-Idiotype Aptamer-Based Electrochemical Sensor for a Humanized Therapeutic Antibody Monitoring
International Journal of Molecular Sciences · 09.03.2023 · 24 (6) · 5277
DOI: 10.3390/ijms24065277 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.03.2023. Verfasst von Madoka Nagata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 2759…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Biosensing Techniques. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UNC/NCSU Joint Department of Biomedical Engineering, Joint Department of Biomedical Engineering.
Abstract (Originalsprache)
Therapeutic monoclonal antibodies (mAbs) are currently the most effective medicines for a wide range of diseases. Therefore, it is expected that easy and rapid measurement of mAbs will be required to improve their efficacy. Here, we report an anti-idiotype aptamer-based electrochemical sensor for a humanized therapeutic antibody, bevacizumab, based on square wave voltammetry (SWV). With this measurement procedure, we were able to monitor the target mAb within 30 min by employing the anti-idiotype bivalent aptamer modified with a redox probe. A fabricated bevacizumab sensor achieved detection of bevacizumab from 1–100 nM while eliminating the need for free redox probes in the solution. The feasibility of monitoring biological samples was also demonstrated by detecting bevacizumab in the diluted artificial serum, and the fabricated sensor succeeded in detecting the target covering the physiologically relevant concentration range of bevacizumab. Our sensor contributes to ongoing efforts towards therapeutic mAbs monitoring by investigating their pharmacokinetics and improving their treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27599, USA.
- Department of Biotechnology and Life Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Koganei 184-8588, Japan.
ORCID-Profile: Jinhee Lee, Kazunori Ikebukuro, Koji Sode
Förderung
- UNC/NCSU Joint Department of Biomedical Engineering
- Joint Department of Biomedical Engineering
Zitieren
APA
Nagata, M., Lee, J., Saito, T., Ikebukuro, K., & Sode, K. (2023). Development of an Anti-Idiotype Aptamer-Based Electrochemical Sensor for a Humanized Therapeutic Antibody Monitoring. International Journal of Molecular Sciences, 24(6), 5277. https://doi.org/10.3390/ijms24065277
Vancouver
Nagata M, Lee J, Saito T, Ikebukuro K, Sode K. Development of an Anti-Idiotype Aptamer-Based Electrochemical Sensor for a Humanized Therapeutic Antibody Monitoring. International Journal of Molecular Sciences. 2023;24(6):5277. doi:10.3390/ijms24065277
BibTeX
@article{Nagata2023,
author = {Nagata, Madoka and Lee, Jinhee and Saito, Taro and Ikebukuro, Kazunori and Sode, Koji},
title = {Development of an Anti-Idiotype Aptamer-Based Electrochemical Sensor for a Humanized Therapeutic Antibody Monitoring},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5277},
doi = {10.3390/ijms24065277}
}
EUVIMED